Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
Digital therapeutics (DTx) are innovative therapeutic interventions, in which the therapeutic activity is carried out by algorithms and software. They represent a new opportunity especially for the treatment of chronic pathologies associated with dysfunctional lifestyles and behaviors, where convent...
Saved in:
Main Authors: | Salvatore Crisafulli (Author), Eugenio Santoro (Author), Giuseppe Recchia (Author), Gianluca Trifirò (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
by: Salvatore Crisafulli, et al.
Published: (2024) -
A New Era of Pharmacovigilance: Future Challenges and Opportunities
by: Gianluca Trifirò, et al.
Published: (2022) -
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective
by: Salvatore Crisafulli, et al.
Published: (2022) -
Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020) -
Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013)